74 related articles for article (PubMed ID: 2244806)
1. Amelioration of cholinergic-induced pancreatitis with a selective cholecystokinin receptor antagonist.
Bilchik AJ; Zucker KA; Adrian TE; Modlin IM
Arch Surg; 1990 Dec; 125(12):1546-9. PubMed ID: 2244806
[TBL] [Abstract][Full Text] [Related]
2. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
J Lab Clin Med; 1993 Oct; 122(4):450-4. PubMed ID: 8228560
[TBL] [Abstract][Full Text] [Related]
3. Effects of the specific cholecystokinin antagonist L 364,718 in experimental acute pancreatitis in the rat.
Sjövall S; Ahrén B; Stenram U
Eur Surg Res; 1988; 20(5-6):325-9. PubMed ID: 2465158
[TBL] [Abstract][Full Text] [Related]
4. Effect of somatostatin analogue and cholecystokinin receptor antagonist on bile-induced acute canine pancreatitis.
Ko TC; Bertram MF; Prinz RA; Castelli M; Djuricin G; Jacobs HK
Am Surg; 1992 Apr; 58(4):213-9. PubMed ID: 1375011
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin augmentation of 'surgical' pancreatitis. Benefits of receptor blockade.
Modlin IM; Bilchik AJ; Zucker KA; Adrian TE; Sussman J; Graham SM
Arch Surg; 1989 May; 124(5):574-8. PubMed ID: 2469410
[TBL] [Abstract][Full Text] [Related]
6. Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice.
Silverman M; Ilardi C; Bank S; Kranz V; Lendvai S
Gastroenterology; 1989 Jan; 96(1):186-92. PubMed ID: 2462522
[TBL] [Abstract][Full Text] [Related]
7. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models.
Tani S; Okabayashi Y; Nakamura T; Fujii M; Itoh H; Otsuki M
Pancreas; 1990 May; 5(3):284-90. PubMed ID: 2343042
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic and protective effect of subcutaneous injections of L-364,718 on caerulein-induced acute pancreatitis.
Garcia-Montero AC; Manso MA; Rodriguez AI; De Dios I
Pancreas; 1994 May; 9(3):309-15. PubMed ID: 7517544
[TBL] [Abstract][Full Text] [Related]
9. Effects of the cholecystokinin receptor antagonist L-364,718 on pancreatitis induced by a deficient in choline and supplemented with ethionine (CDE) diet in the rat.
Manso MA; Rodriguez AI; Garcia-Montero AC; De Dios I
Arch Physiol Biochem; 1995 Aug; 103(4):410-5. PubMed ID: 8548474
[TBL] [Abstract][Full Text] [Related]
10. The role of cholecystokinin in the pathogenesis of acute pancreatitis in the isolated pancreas preparation.
Nordback IH; Clemens JA; Cameron JL
Surgery; 1991 Mar; 109(3 Pt 1):301-6. PubMed ID: 1705726
[TBL] [Abstract][Full Text] [Related]
11. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis.
Jurkowska G; Grondin G; Morisset J
Pancreas; 1992; 7(3):295-304. PubMed ID: 1594550
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis.
Latorre M; Bartolomé-Nebreda JM; García-López MT; González-Muñiz R; Herranz R; Del Río J; Cenarruzabeitia E
Pharmacology; 2004 Oct; 72(2):68-76. PubMed ID: 15331911
[TBL] [Abstract][Full Text] [Related]
13. Possible role of cholecystokinin in the development of acute pancreatitis in rats.
Shinya H; Fujimura M
Nihon Geka Hokan; 1989 Jan; 58(1):3-17. PubMed ID: 2802913
[TBL] [Abstract][Full Text] [Related]
14. Failure of a potent cholecystokinin antagonist to protect against diet-induced pancreatitis in mice.
Ohshio G; Saluja A; Leli U; Sengupta A; Steer ML
Pancreas; 1989; 4(6):739-43. PubMed ID: 2813332
[TBL] [Abstract][Full Text] [Related]
15. Cerulein-induced pancreatitis in the ex vivo isolated perfused canine pancreas.
Clemens JA; Olson J; Cameron JL
Surgery; 1991 Apr; 109(4):515-22. PubMed ID: 2008656
[TBL] [Abstract][Full Text] [Related]
16. Effects of early decompression and cholecystokinin inhibition in rats with acute pancreatitis induced by bile-pancreatic-duct obstruction.
de Dios I; Urunuela A; Manso M
J Lab Clin Med; 2003 Apr; 141(4):265-71. PubMed ID: 12677172
[TBL] [Abstract][Full Text] [Related]
17. Effect of a new cholecystokinin receptor antagonist (KSG 504) on the early stage of the healing process in acute pancreatitis induced in rats by the closed duodenal loop technique.
Ha S; Satake K; Hiura A; Sowa M; Nishiwaki H
Pancreas; 1994 Jul; 9(4):501-7. PubMed ID: 7524065
[TBL] [Abstract][Full Text] [Related]
18. Bile-pancreatic juice replacement not cholinergic- and cholecystokinin-receptor blockade reverses acinar cell hyperstimulation after bile-pancreatic duct ligation.
Samuel I; Joehl RJ
Am J Surg; 1996 Jan; 171(1):207-11. PubMed ID: 8554143
[TBL] [Abstract][Full Text] [Related]
19. A cholecystokinin-releasing factor mediates ethanol-induced stimulation of rat pancreatic secretion.
Saluja AK; Lu L; Yamaguchi Y; Hofbauer B; Rünzi M; Dawra R; Bhatia M; Steer ML
J Clin Invest; 1997 Feb; 99(3):506-12. PubMed ID: 9022085
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin blockade triggers earlier and enhanced intra-acinar oxygen free radical generation in acute pancreatitis induced by pancreatic duct obstruction in rats.
Uruñuela A; Manso MA; de la Mano AM; de Dios I
Clin Sci (Lond); 2003 Aug; 105(2):203-12. PubMed ID: 12713440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
